NovaBay Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NBY and other ETFs, options, and stocks.About NBY
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor.
CEOMichael Kazley
CEOMichael Kazley
Employees14
Employees14
HeadquartersEmeryville, California
HeadquartersEmeryville, California
Founded2000
Founded2000
Employees14
Employees14
NBY Key Statistics
Market cap660.36M
Market cap660.36M
Price-Earnings ratio-3.57
Price-Earnings ratio-3.57
Dividend yield—
Dividend yield—
Average volume4.25M
Average volume4.25M
High today$6.47
High today$6.47
Low today$2.97
Low today$2.97
Open price$3.12
Open price$3.12
Volume30.98M
Volume30.98M
52 Week high$6.47
52 Week high$6.47
52 Week low$0.46
52 Week low$0.46
Stock Snapshot
The current NovaBay Pharmaceuticals(NBY) stock price is $5.44, with a market capitalization of 660.36M. The stock trades at a price-to-earnings (P/E) ratio of -3.57.
As of 2025-12-21, NovaBay Pharmaceuticals(NBY) stock has fluctuated between $2.97 and $6.47. The current price stands at $5.44, placing the stock +83.1% above today's low and -15.9% off the high.
NovaBay Pharmaceuticals(NBY) shares are trading with a volume of 30.98M, against a daily average of 4.25M.
During the past year, NovaBay Pharmaceuticals(NBY) stock moved between $0.46 at its lowest and $6.47 at its peak.
During the past year, NovaBay Pharmaceuticals(NBY) stock moved between $0.46 at its lowest and $6.47 at its peak.
People also own
Based on the portfolios of people who own NBY. This list is generated using Robinhood data, and it’s not a recommendation.